The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors

The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors INTRODUCTIONPancreatic neuroendocrine tumors (PNETs) are relatively rare, but increased detection through imaging of these tumors and subsequent studies have led to an increased understanding of their biologic behavior, which resulted in new diagnostic terminology and a new grading system by the World Health Organization (WHO) in 2010 based on the European Neuroendocrine Tumor Society (ENETS) classification. It has been demonstrated that the WHO grading system is a meaningful prognostic indicator for assessing the clinical outcome of patients who undergo surgical resection of PNETs. Before surgical resection, most PNETs are diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration (FNA) biopsy. Grading of PNETs on FNA, as on surgical resection, is becoming the standard of care, mainly to guide surgical management. The revised 2016 ENETS guidelines recommend curative resection of nonfunctional PNETs in the absence of nonresectable metastases. The possibility of nonoperative management has been investigated for patients who have asymptomatic, sporadic PNETs measuring <2 cm with favorable outcomes, but long‐term follow‐up data are lacking to cement those findings into current practice. Our institution has incorporated grading into the patient‐evaluation algorithm, in conjunction with the updated National Comprehensive Cancer Network (NCCN) guidelines. The 2017 NCCN cancer guidelines incorporate the finding that observation can be http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Cytopathology Wiley

The diagnostic value of FNA biopsy in grading pancreatic neuroendocrine tumors

Loading next page...
 
/lp/wiley/the-diagnostic-value-of-fna-biopsy-in-grading-pancreatic-wP04L8z0XL
Publisher
Wiley
Copyright
© 2018 American Cancer Society
ISSN
1934-662X
eISSN
1934-6638
D.O.I.
10.1002/cncy.21956
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONPancreatic neuroendocrine tumors (PNETs) are relatively rare, but increased detection through imaging of these tumors and subsequent studies have led to an increased understanding of their biologic behavior, which resulted in new diagnostic terminology and a new grading system by the World Health Organization (WHO) in 2010 based on the European Neuroendocrine Tumor Society (ENETS) classification. It has been demonstrated that the WHO grading system is a meaningful prognostic indicator for assessing the clinical outcome of patients who undergo surgical resection of PNETs. Before surgical resection, most PNETs are diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration (FNA) biopsy. Grading of PNETs on FNA, as on surgical resection, is becoming the standard of care, mainly to guide surgical management. The revised 2016 ENETS guidelines recommend curative resection of nonfunctional PNETs in the absence of nonresectable metastases. The possibility of nonoperative management has been investigated for patients who have asymptomatic, sporadic PNETs measuring <2 cm with favorable outcomes, but long‐term follow‐up data are lacking to cement those findings into current practice. Our institution has incorporated grading into the patient‐evaluation algorithm, in conjunction with the updated National Comprehensive Cancer Network (NCCN) guidelines. The 2017 NCCN cancer guidelines incorporate the finding that observation can be

Journal

Cancer CytopathologyWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off